Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check7 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor version update to the page assets or documentation.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site shows a revision upgrade from v3.6.3 to v3.6.4, indicating a minor release. It does not modify the study details or other user-facing content on the page.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, indicating a new page revision. This implies minor internal updates with no user-visible changes to content or functionality.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page shows a newer revision tag, updating from v3.6.0 to v3.6.2, indicating an updated version of the study details page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now includes a recruitment status update indicating no participant enrollment, adds user-focused sections (How to Read a Study Record, Common Questions, How to Join a Study), and standardizes the Intervention/Treatment label while updating the revision to v3.6.0 (removing the previous v3.5.5).SummaryDifference0.2%

- Check72 days agoChange DetectedThe page revision was updated to v3.5.5, replacing the previous v3.5.4 revision. This indicates a minor update to the document on the ClinicalTrials.gov page.SummaryDifference0.0%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.